Welcome to the INA-RESPOND public website.
Current and expanding infectious disease profile in Indonesia warrants a sense of urgency and mandates that research be a priority to guide the management and prevention of disease to reduce morbidity and mortality. The purpose of Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is to bring together clinical and academic medical institutions to develop a robust collaborative infectious disease research network.
By: Aly Diana Anything quantum scares me—like, totally scares me. But lately, I’ve decided that it’s time to explore things that scare me and try to understand them, hoping they become less terrifying. Spoiler alert: it doesn’t make things any less scary. Instead, it turns into this wild ride of “scary but interesting.” So here
Read moreBy: Edrick Purnomo Putra Nowadays, difficulty in sleeping or sleeping disorders are highly prevalent, especially in adults. One of the most common types of sleeping disorders is insomnia, and it is estimated that one-third of the global population suffers from symptoms of insomnia. Insomnia is also more prevalent in older adults, females, and individuals with
Read moreBy: Restu Amalia Mukti, Adhella Menur Cervical cancer has a significant impact on women and families in Indonesia, with over 103 million women aged 15 and older at risk. It is the second most common cancer among women after breast cancer, with approximately 36,964 new cases diagnosed annually. Alarmingly, around 70% of cases are detected
Read moreBy: Erni, Adhella Menur The mumps outbreak in Indonesia The earliest description of mumps as a disease dates back to the 5th century BC by Hippocrates. One notable passage describes: “Swellings appeared about the ears, in many on either side, and in the greatest number on both sides. They were of a lax, large, diffused
Read moreBy: Aly Diana I have never considered myself a gamer, but I was thrilled to discover that a mini-game embedded in Borderlands 3 is reaching its audience—scientists and non-scientists alike—to advance science. This idea struck me as nothing short of brilliant: low cost, high yield, and impactful on a massive scale. During this discovery period,
Read moreBy: Adhella Menur As a member of the INA-RESPOND Science team, I am thrilled with the acceptance of the first publication from our HIV study, entitled “A Prospective Observational Cohort Study of HIV Infection in Indonesia: Baseline Characteristics and One-Year Mortality” in the BMC Infectious Dis-eases journal. This paper provides valuable evidence for Indonesia and
Read moreBy: Meity Siahaan, Dedy Hidayat On December 4-5, 2024, a delegation from the Indonesian Ministry of Health (MoH) visited the United States National Institutes of Health (NIH) to strengthen existing collaborations and explore new opportunities in health research. This visit was an important step in strengthening bilateral cooperation in clinical research and capacity building between
Read moreBy: Aaron Neal INA-RESPOND has much to celebrate over the past year, and much to be excited for in 2025. Highlights from 2024 include the completion of the InVITE study, presentations at the annual Re-PORT tuberculosis (TB) meeting in Brazil, and the acceptance of key publications from HIV study (INA-PROACTIVE) and TB study (TRIPOD). Despite
Read moreBy: INA-RESPOND NSC Members and Secretariat New Year, New Hope! To move forward with strength, we must first reflect on the journey that has brought us here. Over the past 14 years, INA-RESPOND has grown into a center of excellence in infectious disease research in Indonesia. This achievement would not have been possible with-out the
Read more
Sering men
Vaksin atau Deteksi Dini? Mana yang Lebih Pen
Jangan Anggap Remeh! Infeksi Bisa Berujung 
Peribahasa 
